NMRA – neumora therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Neumora Therapeutics, Inc. (NASDAQ: NMRA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Neumora Therapeutics, Inc. (NASDAQ: NMRA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $23.00 price target on the stock.
Neumora Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Neumora Therapeutics to Participate in Upcoming Conferences in November
Neumora Therapeutics, Inc. (NASDAQ: NMRA) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $15.00 price target on the stock, down previously from $18.00.
Form SC 13G Neumora Therapeutics, Filed by: SOFTBANK GROUP CORP.
Form 10-Q Neumora Therapeutics, For: Sep 30
Form 8-K Neumora Therapeutics, For: Nov 12
Form 4 Neumora Therapeutics, For: Oct 17 Filed by: Fust Matthew K
Form 144 Neumora Therapeutics, Filed by: Fust Matthew K
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.